Drugs / 68Ga-SFB6-ZN01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07420036 | Mar 2026 → Dec 2028 expected | neoplasm | Zhongnan Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-SFB6-ZN01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07420036 ↗ |
| Modality | Diagnostic / imaging agent | “68Ga-SFB6-ZN01 is a novel PET radiotracer” NCT07420036 ↗ |
| Route | Intravenous | “All enrolled subjects will receive a single intravenous bolus injection of 68Ga-SFB6-ZN01” NCT07420036 ↗ |